Literature DB >> 31992601

Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.

Yoo-Na Kim1, Kyung Jin Eoh1, Jung-Yun Lee1, Eun Ji Nam1, SungHoon Kim1, Young-Tae Kim1, Sang Wun Kim2.   

Abstract

INTRODUCTION: Fluorescence image-guided sentinel lymph node (SLN) biopsy using a two-step mapping technique incorporates sequential injection of indocyanine green into the bilateral uterine cornus, followed by cervical injection. Outcomes were compared with the conventional cervical (one-step) method .
METHODS: Patients with FIGO stage I-III endometrial cancer who underwent laparoscopic or robotic staging, including SLN biopsy, from May 2014 to December 2018, were retrospectively reviewed. Patient characteristics, pre-operative imaging, SLN detection pattern, pathologic result, adjuvant, and recurrence locations were analyzed.
RESULTS: A total of 199 patients received one-step (n=123) and two-step (n=76) SLN biopsy. Para-aortic SLN were more frequently identified in the two-step group. Lower and upper para-aortic SLN were identified in 67.1% and 38.2%, respectively, in the two-step group and in 18.7% and 5.7% in the one-step group (p<0.001). The number of para-aortic SLN harvested was superior in the two-step group (p<0.001). Metastatic para-aortic SLN were found in 7.9% of the two-step group and 2.4% of the one-step group (p=0.070). In detecting nodal metastasis, the sensitivities of the one- and two-step methods were 91.7% and 100.0%, negative predictive values were 99.0% and 100.0%, false-negative rates were 8.3% and 0%, and accuracy rates were 99.1% and 100.0%, respectively. The one-step method identified only three out of eight para-aortic lymph node metastases and missed five para-aortic lymph node metastases. There was no missed para-aortic lymph node metastasis in the two-step group. Recurrence was observed in two patients (2.6%; vaginal vault and adrenal gland) in the two-step group and seven patients (5.7%) including three nodal recurrences in the one-step group (p=0.307). DISCUSSION: Two-step SLN mapping improved the para-aortic SLN detection rate, a known pitfall of conventional cervical injection. Proper evaluation of aortic nodal status will assist in the tailoring of adjuvant and prevent undertreatment of patients with isolated para-aortic metastasis. © IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  endometrial neoplasms; lymphatic metastasis; neoplasm recurrence, local; sentinel lymph node

Year:  2020        PMID: 31992601     DOI: 10.1136/ijgc-2019-000962

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Sentinel Lymph Node Biopsy in Endometrial Cancer: Dual Injection, Dual Tracer-A Multidisciplinary Exhaustive Approach to Nodal Staging.

Authors:  Anna Torrent; Joana Amengual; Catalina Maria Sampol; Mario Ruiz; Jorge Rioja; Gabriel Matheu; Pilar Roca; Octavi Cordoba
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

2.  Pattern of Lymph Node Metastasis in Endometrial Cancer: a Single Institution Experience.

Authors:  S Suchetha; Arun Peter Mathew; P Rema; Shaji Thomas
Journal:  Indian J Surg Oncol       Date:  2020-09-28

3.  Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues.

Authors:  Yoo-Na Kim; Young Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2022-08-02

4.  Robotic Staging of Cervical Cancer With Simultaneous Detection of Primary Pelvic and Secondary Para-Aortic Sentinel Lymph Nodes: Reproducibility in a First Case Series.

Authors:  Philippe Van Trappen; Eveline De Cuypere; Nele Claes; Sarah Roels
Journal:  Front Surg       Date:  2022-06-16

Review 5.  Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review.

Authors:  Lirong Zhai; Xiwen Zhang; Manhua Cui; Jianliu Wang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.